Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Ekman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Cell Biology|April 27, 2005
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2Pipsa Saharinen, Katja Kerkelä, Niklas Ekman, et al.
Nature Genetics|March 4, 2008
LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposisPekka Katajisto, Kari Vaahtomeri, Niklas Ekman, et al.
Drugs|April 1, 2025
The Tailored Biosimilar Approach: Expectations and RequirementsElena Guillen, Sean Barry, Nils Jost, et al.
Blood|October 25, 2012
Biosimilars: what clinicians should knowMartina Weise, Marie-Christine Bielsky, Karen De Smet, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Cell Biology|April 27, 2005
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2Pipsa Saharinen, Katja Kerkelä, Niklas Ekman, et al.
Nature Genetics|March 4, 2008
LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposisPekka Katajisto, Kari Vaahtomeri, Niklas Ekman, et al.
Drugs|April 1, 2025
The Tailored Biosimilar Approach: Expectations and RequirementsElena Guillen, Sean Barry, Nils Jost, et al.
Blood|October 25, 2012
Biosimilars: what clinicians should knowMartina Weise, Marie-Christine Bielsky, Karen De Smet, et al.
Pageof 2